NGL Fine Chem Ltd is Rated Hold

1 hour ago
share
Share Via
NGL Fine Chem Ltd is rated Hold by MarketsMojo, with this rating last updated on 17 August 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 20 September 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and market standing.
NGL Fine Chem Ltd is Rated Hold

Understanding the Current Rating

The Hold rating assigned to NGL Fine Chem Ltd indicates a balanced outlook where the stock is neither a strong buy nor a sell at present. This recommendation suggests that investors should maintain their existing positions but exercise caution before adding new exposure. The rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals, each contributing to the overall assessment of the company’s investment appeal.

Quality Assessment

As of 20 September 2026, NGL Fine Chem Ltd’s quality grade is considered average. The company maintains a conservative capital structure with a low average debt-to-equity ratio of 0.05 times, reflecting minimal leverage and a stable financial foundation. However, long-term growth has been a concern, with operating profit declining at an annualised rate of -4.18% over the past five years. Despite this, recent quarters have shown improvement, with the company reporting very positive net profit growth of 99.13% in the latest quarter ending June 2026. This mixed quality profile suggests that while the company has some operational challenges, it is demonstrating resilience and potential for recovery.

Valuation Considerations

The valuation grade for NGL Fine Chem Ltd is currently classified as expensive. The stock trades at a premium relative to its peers, with an enterprise value to capital employed ratio of 4.5 and a return on capital employed (ROCE) of 13.3%. This elevated valuation is supported by strong profit growth, as the company’s profits have surged by 174.1% over the past year. The price-to-earnings-to-growth (PEG) ratio stands at a low 0.2, indicating that despite the premium price, earnings growth justifies some of the valuation. Investors should weigh this premium against the company’s growth prospects and sector dynamics before making investment decisions.

Financial Trend and Performance

Currently, the company’s financial metrics indicate a very positive trend. The latest quarterly results show net sales of ₹139.16 crores, growing at 33.56%, with the highest recorded PBDIT of ₹23.28 crores and PBT less other income at ₹17.05 crores. These figures reflect strong operational momentum and improving profitability. Over the past year, the stock has delivered an impressive return of 104.15%, significantly outperforming many peers in the Pharmaceuticals & Biotechnology sector. Year-to-date returns stand at 97.27%, underscoring robust investor confidence. However, the company’s poor long-term operating profit growth tempers enthusiasm, suggesting that recent gains may be cyclical or driven by short-term factors.

Technical Analysis

The technical grade for NGL Fine Chem Ltd is mildly bullish. The stock has shown positive momentum in the short term, with a one-day gain of 2.62% and a one-week increase of 4.36%. Despite some volatility reflected in a one-month decline of 8.09% and a three-month drop of 8.67%, the six-month performance remains strong at +26.54%. This technical profile suggests that while the stock has experienced some short-term corrections, the overall trend remains upward, supported by recent positive earnings and market sentiment.

Investor Implications

For investors, the Hold rating on NGL Fine Chem Ltd signals a cautious approach. The company’s strong recent earnings growth and impressive stock returns are encouraging, but the expensive valuation and average quality metrics warrant prudence. Investors should monitor upcoming quarterly results and sector developments closely to assess whether the company can sustain its positive momentum. Given the stock’s premium pricing and mixed fundamentals, new investors might consider waiting for a more attractive entry point, while existing shareholders may choose to hold and reassess as new data emerges.

Additional Market Insights

It is noteworthy that domestic mutual funds currently hold no stake in NGL Fine Chem Ltd. Given their capacity for in-depth research and on-the-ground analysis, this absence may indicate reservations about the company’s valuation or business prospects at current levels. This factor adds another layer of caution for investors considering fresh exposure.

From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!

  • - Early turnaround signals
  • - Explosive growth potential
  • - Textile - Machinery recovery play

Position for Explosive Growth →

Sector and Market Context

NGL Fine Chem Ltd operates within the Pharmaceuticals & Biotechnology sector, a space characterised by innovation, regulatory challenges, and evolving market dynamics. The company’s microcap status means it is more susceptible to volatility and liquidity constraints compared to larger peers. Investors should consider sector trends, including drug development pipelines, regulatory approvals, and competitive pressures, when evaluating the stock’s prospects. The company’s recent strong quarterly sales growth and profitability improvements suggest it is navigating these challenges effectively, but the long-term sustainability of this performance remains to be seen.

Summary of Key Metrics as of 20 September 2026

NGL Fine Chem Ltd’s Mojo Score currently stands at 64.0, reflecting the Hold rating. The stock’s returns over various periods highlight strong recent performance: 1-day +2.62%, 1-week +4.36%, 6-month +26.54%, YTD +97.27%, and 1-year +104.15%. Despite these gains, the company’s operating profit has declined over five years at an annualised rate of -4.18%, signalling underlying challenges. The valuation remains expensive, with a ROCE of 13.3% and an enterprise value to capital employed ratio of 4.5. These metrics collectively justify the Hold stance, balancing growth potential against valuation and quality concerns.

Conclusion

In conclusion, NGL Fine Chem Ltd’s Hold rating by MarketsMOJO reflects a nuanced view of the company’s current investment profile. While recent financial trends and stock returns are encouraging, the expensive valuation and average quality metrics counsel caution. Investors should maintain existing holdings but remain vigilant for changes in fundamentals or market conditions that could warrant a reassessment. This rating serves as a guide to balance opportunity with risk in a dynamic sector environment.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News